Possibilities of atorvastatin loading dose using for the prevention of perioperative myocardial damage in patients with stable coronary artery disease
https://doi.org/10.15829/1728-8800-2019-5-23-26
Abstract
The aim was to assess the effect of a single atorvastatin loading dose on reducing the frequency of perioperative myocardial damage. Perioperative myocardial damage is a complication of endovascular revascularization of the coronary arteries. This complication significantly aggravates the operative and life prognosis of the patients. Atorvastatin loading dose has a protective effect, which can significantly reduce the percentage of perioperative myocardial damage and therefore improve the patient’s prognosis. This article presents an analysis of studies, dedicated to the effect of atorvastatin loading dose on perioperative myocardial damage in patients with stable coronary artery disease.
About the Authors
A. S. Ragozina
District Cardiac Dispensary “Center for Diagnostic and Cardiovascular Surgery”
Russian Federation
Russian Federation
I. V. Petrenko
District Cardiac Dispensary “Center for Diagnostic and Cardiovascular Surgery”; Surgut State University
Russian Federation
Russian Federation
I. A. Urvantseva
District Cardiac Dispensary “Center for Diagnostic and Cardiovascular Surgery”; Surgut State University
Russian Federation
Russian Federation
V. G. Titanov
District Cardiac Dispensary “Center for Diagnostic and Cardiovascular Surgery”
Russian Federation
Russian Federation
K. Yu. Nikolaev
Research Institute of Therapy and Preventive Medicine
Russian Federation
Russian Federation
Novosibirsk
References
1. Informacionnyj byulleten' № 317: VOZ. Mart 2013. (In Russ.) Информационный бюллетень № 317: ВОЗ. Март, 2013.
2. Lo N, Michael TT, Moin D, et al. Periprocedural Myocardial Injury in Chronic Total Occlusion Percutaneous Interventions A Systematic Cardiac Biomarker Evaluation Study. JACC. 2014;7(1):47-54. doi:10.1016/j.jcin.2013.07.011.
3. Lu C, Jia H, Wang Z. High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention. Oncotarget. 2017;8(41):70356-65. doi:10.18632/oncotarget.19701.
4. Nafasi L, Rahmani R, Shafiee A, et al. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction? Current Medical Research and Opinion. 2014;30(3):381-6. doi:10.1185/03007995.2013.834249.
5. Guo X, Huang X, Wang Q. Effect of intensive pretreatment with atorvastatin calcium on outcomes of percutaneous coronary intervention in elderly patients with coronary heart disease. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35(2):295-300.
6. Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE. Randomized Trial. JACC. 2009;54(6):558-65. doi:101016/j.jacc.2009.05.028.
7. He GX, Tan W. High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention. Journal of Geriatric Cardiology. 2013;10(4):355-60. doi:10.3969/j.issn.1671-5411.2013.04.013.
8. Hoeks S, Welten G. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Journal of Vascular Surgery. 2008;47(2):478.
9. Briguori C, Visconti G. Novel Approaches for Preventing or Limiting Events (Naples) II Trial: Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction. JACC. 2009;54(23):2157-63. doi:10.1016/j.jacc.2009.07.005.
10. Ye H, He F, Fei X, et al. High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period. Journal of Cardiovascular Pharmacology and Therapeutics. 2014;19(3):290-5. doi:10.1177/1074248413513500.
11. Ragozina AS, Petrenko IV, Gor'kov AI, et al. Evaluation of cardiac markers level and myocardium functional state in patients with recanalization of chronic total occlusions of coronary arteries with atorvastatin loading doses. Kompleksnye problemy serdechno-sosudistyh zabolevanij. 2018;1:29-35. (In Russ.) doi:10.17802/2306-1278-2018-7-1-29-35.
12. Antman EM, Morrow DA. Biomarker Release After Percutaneous Coronary Intervention. Circulation: Cardiovascular Interventions. 2008;1(1):3-6. doi:10.1161/CIRCINTERVENTIONS.108.799858.
13. Gajendragadkar R, Cooper G, Walsh R, et al. Novel uses for statins in surgical patients. International Journal of Surgery. 2009;7(4):285-90. doi:10.1016/j.ijsu.2009.04.016.
14. Ragozina AS, Petrenko IV, Gor'kov AI, et al. Statins protective role in patients with chronic total occlusions of coronary arteries in intracoronary interventions. Ateroskleroz. 2018;14(1):23-31. (In Russ.)
Review
For citations:
Ragozina A.S., Petrenko I.V., Urvantseva I.A., Titanov V.G., Nikolaev K.Yu. Possibilities of atorvastatin loading dose using for the prevention of perioperative myocardial damage in patients with stable coronary artery disease. Cardiovascular Therapy and Prevention. 2019;18(5):23-26. (In Russ.) https://doi.org/10.15829/1728-8800-2019-5-23-26
Views:
571
Email this article 
